Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease

Cholinesterase inhibitors constitute one of the mainstays of treatment of Alzheimer disease (AD). Gastrointestinal side effects, difficulty accessing therapeutic doses and poor patient compliance have been identified as barriers to effective treatment with these substances. The rivastigmine transder...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:CNS Neurosci Ther
Autori principali: Emre, Murat, Bernabei, Roberto, Blesa, Rafael, Bullock, Roger, Cunha, Luis, Daniëls, Hugo, Dziadulewicz, Edward, Förstl, Hans, Frölich, Lutz, Gabryelewicz, Tomasz, Levin, Oleg, Lindesay, James, Martínez‐Lage, Pablo, Monsch, Andreas, Tsolaki, Magda, Van Laar, Teus
Natura: Artigo
Lingua:Inglês
Pubblicazione: Blackwell Publishing Ltd 2010
Soggetti:
Alzheimer's Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6493902/
https://ncbi.nlm.nih.gov/pubmed/20370805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1755-5949.2010.00141.x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi